Does your organization support the meaningful engagement of individuals with lived experience of substance use? The assumption and our immediate response to this question should be a resounding yes! However, we know that this is often not the case.
British Columbians can now be diagnosed with hepatitis C from a single blood test, saving time and money for both patients and the health care system. This is thanks to a new testing process introduced by the Public Health Laboratory at the B.C. Centre for Disease Control (BCCDC), known as hepatitis C (HCV) RNA reflex testing.
To end the HIV epidemic in Canada, it is important for people who are HIV-positive to know their status and to be linked to care. To do that, we have to reach people who are not testing now and make the process easier for them.
Many creative solutions have been implemented to keep people who use drugs safe, and these solutions need to be scaled up and continued beyond the pandemic, to reach people who don’t live in areas with adequate harm reduction services.
Immediately after Ontario declared the novel coronavirus disease (COVID-19) as being a public health emergency in mid-March 2020, all visits from family and friends and programming were suspended in prisons in the province.
With little information from the Ministry of the Solicitor General regarding their efforts to contain the spread of COVID-19, the Prisoners’ HIV/AIDS Support Action Network (PASAN) was flooded with phone calls from prisoners concerned about their health and the well-being of their family and friends.
This June, CATIE and the Canadian Network on Hepatitis C (CanHepC) co-hosted a webinar on sustaining the hepatitis C response before and after the novel coronavirus disease (COVID-19) pandemic. We invited leaders in the hepatitis C field to explore the challenges that the pandemic has posed for hepatitis C elimination efforts, but also the opportunities that could be leveraged. Here are just five of the ways we can do this:
